Well, I won my bet with myself, although there was little chance I would lose: As expected, the American media has utterly ignored the story that UK scientists have transformed umbilical cord blood stem cells into “mini livers,” not working livers, mind you, but liver tissue the size of a dime that can be used in drug testing and, hopefully, will one day be developed into a therapy for liver disease. Indian media reported it. So did Australian news. There was even a small report in Turkey.
Sadly, the research breakthrough just wasn’t up to rigorous US media standards since the scientists didn’t use the right kind of stem cells.
But they shouldn’t lose hope! They still have time to receive American media acclaim. All they have to do is go back to the lab and do it again—only this time with mouse embryonic stem cells. Then, the New York Times is sure to put their pictures on the front page.
Our Most Popular Articles of 2025
It’s been a big year for First Things. Our website was completely redesigned, and stories like the…
Our Year in Film & Television—2025
First Things editors and writers share the most memorable films and TV shows they watched this year.…
Religious Freedom Is the Soul of American Security
In the quiet sanctuary of West Point’s Old Cadet Chapel, a striking mural crowns the apse above…